Dual-Acting Vitamin B 3 -Melanostatin Neuropeptide Hybrids as Potent Modulators of the Dopamine D 2 Receptors with Neuroprotective Activity
Authors:
- Beatriz L. Pires-LimaBPBeatriz L. Pires-Lima
- Sara C. Silva-ReisSSSara C. Silva-Reis
- Xavier Cruz CorreiaXCXavier Cruz Correia
- Hugo F. Costa-AlmeidaHCHugo F. Costa-Almeida
- Vera M. CostaVera M. Costa
- Xerardo García-MeraXGXerardo García-Mera
- José BreaJBJosé Brea
- María I. LozaMLMaría I. Loza
- Marialessandra ContinoMarialessandra Contino
- Maria Grazia PerroneMaria Grazia Perrone
- Giovanni GrazianoGiovanni Graziano
- Nuno ValeNuno Vale
Open Access
- 18 June 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (13) , 15597-15613
Abstract
Parkinson's disease (PD) therapy remains limited by complications of the levodopa regimen, highlighting the need for novel therapeutic strategies to modulate dopaminergic signaling. Melanostatin (MIF-1) has attracted attention as a privileged scaffold for dopamine D2 receptor (D2R) modulation due to its intrinsic positive allosteric modulatory activity, although improved potency and drug-like properties are required for translation. In this work, nicotinic acid (Nic), a vitamer of vitamin B3, was employed as a proline (Pro) bioisostere, generating 12 vitamin B3-MIF-1 hybrids. Nicotinoyl-l-leucylglycinamide (6c) emerged as a lead compound, promoting a 5.11-fold enhancement of dopamine potency at 0.01 nM and displaying neuroprotective activity at 50-100 μM in dopaminergic-differentiated SH-SY5Y cells. Additionally, Pro-to-Nic substitution showed no cytotoxicity in HepG2, reduced P-glycoprotein-mediated efflux, and preserved β-turn conformational propensity, supporting improved oral drug-like properties. Collectively, these findings identify 6c as a dual-acting lead and establish Nic as a privileged Pro surrogate for next-generation MIF-1-based PD therapeutics.Keywords
Funding Information
- Agencia Estatal de Investigación (PID2021-124010OB-100)
- European Regional Development Fund (15152)
- European Regional Development Fund (COMPETE2030-FEDER-00881500)
- Fundação para a Ciência e a Tecnologia (2020.02311.CEECIND/CP1596/CT0004)
- Fundação para a Ciência e a Tecnologia (2022.14060.BD)
- Fundação para a Ciência e a Tecnologia (2023.14440.PEX)
- Fundação para a Ciência e a Tecnologia (2024.02245.BD)
- Fundação para a Ciência e a Tecnologia (2024.18026.PEX)
- Fundação para a Ciência e a Tecnologia (IF/00092/2014/CP1255/CT0004)
- Fundação para a Ciência e a Tecnologia (LA/P/0053/2020)
- Fundação para a Ciência e a Tecnologia (LA/P/0140/2020)
- Fundação para a Ciência e a Tecnologia (PRR-09/C06-834I07/2024.P11721)
- Fundação para a Ciência e a Tecnologia (SFRH/BD/147463/2019)
- Fundação para a Ciência e a Tecnologia (UI/BD/154888/2023)
- Fundação para a Ciência e a Tecnologia (UID/50006/2025)
- Fundação para a Ciência e a Tecnologia (UIDB/04378/2020)
- Fundação para a Ciência e a Tecnologia (UIDB/4255/2020)
- Fundação para a Ciência e a Tecnologia (UIDP/04378/2020)
- Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia (ED431B 2023/25)
This publication has 64 references indexed in Scilit:
- Discovery of first-in-class melanostatin-based ago-allosteric modulators of the dopamine D2 receptorsBiomedicine & Pharmacotherapy, 2026
- The Promise of Niacin in NeurologyNeurotherapeutics, 2023
- The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discoveryBiopharmaceutics & Drug Disposition, 2022
- Use of Liver-Derived Cell Lines for the Study of Drug-Induced Liver Injury2018
- Preparation of Constrained Unnatural Aromatic Amino Acidsvia Unsaturated Diketopiperazine IntermediateJournal of Heterocyclic Chemistry, 2015
- The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrationsArchives of Toxicology, 2013
- Postsynaptic nigrostriatal dopamine receptors and their role in movement regulationJournal of Neural Transmission, 2010
- Pharmacokinetics of levodopaJournal of Neurology, 2010
- Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elementsJournal of Molecular Modeling, 2007
- Analysis and prediction of the different types of β-turn in proteinsJournal of Molecular Biology, 1988